Characterisation of transient benign hCG elevations in women following chemotherapy for GTT

Journal of Obstetrics and Gynaecology

Volumn 31, Issue 2, 2011, Pages 169-172

  White, S ^a   Harvey, R ^a   Mitchell, H ^a   Schmid, P ^a   Seckl, M ^a   Savage, P ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; choriocarcinoma; GTT; hCG

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ESTRADIOL; ETOPOSIDE; FOLINIC ACID; FOLLITROPIN; IFOSFAMIDE; LUTEINIZING HORMONE; METHOTREXATE; PACLITAXEL; VINCRISTINE;

ADULT; ARTICLE; BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CASE REPORT; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GERM CELL TUMOR; HUMAN; HYSTERECTOMY; LUTEINIZING HORMONE BLOOD LEVEL; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; POSTMENOPAUSE; PRIORITY JOURNAL; TROPHOBLASTIC TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ESTRADIOL; ETOPOSIDE; FEMALE; FOLLICLE STIMULATING HORMONE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IFOSFAMIDE; LEUCOVORIN; LUTEINIZING HORMONE; METHOTREXATE; PREGNANCY; RETROSPECTIVE STUDIES; TAXOIDS; VINCRISTINE; YOUNG ADULT;

EID: 79551567670     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2010.536859     Document Type: Article

References (8)

1. Cole LA, Sasaki Y, Muller CY. 2007. Normal production of human chorionic gonadotropin in menopause. New England Journal of Medicine 356:1184-1186.
2. FIGO Oncology Committee. 2002. FIGO staging for gestational trophoblastic neoplasia. International Journal of Gynaecology and Obstetrics 77:285-287.
3. Gronowski AM, Fantz CR, Parvin CA, Sokoll LJ, Wiley CL, Wener MH et al. 2008. Use of serum FSH to identify perimenopausal women with pituitary hCG. Clinical Chemistry 54:652-656.
4. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ et al. 2002. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. Journal of Clinical Oncology 20:1838-1844.
5. Murugaesu N, Schmid P, Dancey G, Agarwal R, Holden L, McNeish I et al. 2006. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. Journal of Clinical Oncology 24:4862-4866.
6. Rotmensch S, Cole LA. 2000. False diagnosis and needless therapy of presumed malignant disease in women with falsepositive human chorionic gonadotropin concentrations. Lancet. 355:712-715.
7. Simpson ER. 2003. Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86:225-230. van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ
8. van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ,Sweep FC, Thomas CM. 2006. Early identification of resistance to first line single agent methotrexate in patients with persistent trophoblastic disease. Journal of Clinical Oncology 24:52-58.